- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03124342
Vanderbilt ICU Recovery Program Pilot Trial (VIP)
October 7, 2019 updated by: Matthew Semler, Vanderbilt University Medical Center
Every year, millions of Americans are admitted to the intensive care unit.
Due to advances in critical care, mortality rates are decreasing, increasing the number of ICU survivors.
Survivors of critical illness, however, often face physical, functional, and cognitive deficits that place them at risk for a cycle of re-hospitalization that frequently culminates in premature death.
Moreover, post-ICU interventions may be resource-intensive and may be most cost-effective only in a subgroup of patients at highest risk.
Whether a multi-disciplinary program to facilitate recovery from critical illness can prevent hospital readmission and improve quality of life among high-risk ICU survivors remains unknown.
The primary aim of this pilot is to examine the feasibility of implementing a multidisciplinary ICU Recovery Program and the influence of such a program on process measures including contact with the ICU recovery team and attendance of ICU recovery clinic.
The secondary aims are to compare the effect of an ICU Recovery Program on 30-day same-hospital readmission and other clinical outcomes.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
232
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Tennessee
-
Nashville, Tennessee, United States, 37232
- Vanderbilt University Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age ≥ 18 years
- Admitted to the Medical Intensive Care Unit (MICU) at Vanderbilt University Medical Center for at least 48 hours
- Estimated risk of 30-day same-hospital readmission greater than 15%
- Not previously enrolled in the study.
Exclusion Criteria:
- Long-term residence at a skilled nursing facility
- Long-term mechanical ventilation prior to admission
- Solid organ or stem cell transplantation
- Recorded primary residency > 200 miles from Vanderbilt
- Comfort care only
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: VANDERBILT ICU RECOVERY PROGRAM (VIP)
Patients assigned to the Vanderbilt ICU Recovery Program (VIP) group will receive the components of the ICU Recovery Program intervention.
|
10-component ICU Recovery Program intervention, including:
Other Names:
|
|
No Intervention: Usual care
Patients in the usual care group will receive care as dictated by their clinical team.
In usual care in the study institution, patients frequently receive medication reconciliation by and ICU pharmacist at the time of transfer out of the ICU to the hospital ward, medication reconciliation by a physician at the time of hospital discharge, and follow up with their primary care physician within two weeks of hospital discharge.
Usual care does not currently include an in-person assessment of the patient's cognitive and functional status or anticipated post-ICU needs by a nurse practitioner between ICU transfer and hospital discharge, access to a 24/7 contact line after hospital discharge, or assessment in a multi-disciplinary ICU Recovery Clinic.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Components of the ICU Recovery Program Received
Time Frame: From the time of study enrollment to 30 days after hospital discharge
|
Number of components of the ICU Recovery Program intervention received by patients between ICU transfer and 30 days after hospital discharge.
The 10-components considered part of the ICU Recovery Program include: (1) nurse practitioner in-person visit between ICU transfer and hospital discharge, (2) ICU Recovery Program pamphlet, (3) pharmacist medication reconciliation at the time of ICU transfer, (4) ICU Recovery Program contact line, (5) nurse practitioner history and physical in ICU Recovery Clinic, (6) pharmacist medication reconciliation in ICU Recovery Clinic, (7) cognitive/mental health assessment and psychoeducation in ICU Recovery Clinic, (8) case management consultation in ICU Recovery Clinic, (9) patient centered consultation with pulmonary and critical care medicine physician in ICU Recovery clinic, (10), directed subspecialty referrals.
|
From the time of study enrollment to 30 days after hospital discharge
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants With Same-hospital Readmission in the 30 Days After Hospital Discharge
Time Frame: Within 30 days of hospital discharge
|
Readmission to the study hospital in the 30 days after hospital discharge
|
Within 30 days of hospital discharge
|
|
Number of Participants Death or Readmission in the 30 Days After Hospital Discharge
Time Frame: Within 30 days of hospital discharge
|
Composite outcome of death or readmission in the 30 days after hospital discharge
|
Within 30 days of hospital discharge
|
|
Number Participants With Same-hospital Emergency Department Visits in the 30 Days After Hospital Discharge
Time Frame: Within 30 days of hospital discharge
|
Within 30 days of hospital discharge
|
|
|
Number of Same-hospital Outpatient Clinic Visits in the 30 Days After Hospital Discharge
Time Frame: Within 30 days of hospital discharge
|
Within 30 days of hospital discharge
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Joanna Stollings, PharmD, Vanderbilt University Medical Center
- Study Chair: Carla Sevin, MD, Vanderbilt University Medical Center
- Principal Investigator: Matthew W Semler, MD, MSc, Vanderbilt University Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2017
Primary Completion (Actual)
October 31, 2017
Study Completion (Actual)
April 30, 2018
Study Registration Dates
First Submitted
April 18, 2017
First Submitted That Met QC Criteria
April 18, 2017
First Posted (Actual)
April 21, 2017
Study Record Updates
Last Update Posted (Actual)
October 8, 2019
Last Update Submitted That Met QC Criteria
October 7, 2019
Last Verified
October 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 170126
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intensive Care Unit Syndrome
-
University of MelbourneEnrolling by invitationICU Acquired Weakness | Intensive Care Unit Syndrome | Intensive Care Unit Acquired Weakness | Post Intensive Care Unit Syndrome | Post Intensive Care SyndromeAustralia
-
Indiana UniversityIndiana University HealthRecruitingPost Intensive Care Unit Syndrome | Intensive Care Unit Delirium | Intensive Care Acquired Cognitive Impairment | Virtual Reality Cognitive TrainingUnited States
-
University Hospital, BrestNot yet recruitingIntensive Care Unit SyndromeFrance
-
Zealand University HospitalNot yet recruitingPost-Intensive Care Syndrome (PICS) | Intensive Care Unit (ICU) Patients | Symptom Burden
-
Assistance Publique - Hôpitaux de ParisRecruitingIntensive Care Unit Syndrome | Pediatric Post-intensive Care SyndromeFrance
-
Medical Centre LeeuwardenCompletedCritical Illness | Intensive Care Unit Acquired Weakness | Post Intensive Care Unit SyndromeNetherlands
-
Hospital Felix BulnesCompletedMechanical Ventilation Complication | Intensive Care Unit Syndrome | Intensive Care Unit Acquired Weakness | Intensive Care Unit Delirium | Intensive Care NeuropathyChile
-
University of CalgaryCanadian Institutes of Health Research (CIHR)CompletedDelirium | Post Intensive Care Unit Syndrome | Intensive Care Unit Delirium | Post Intensive Care Unit Syndrome FamilyCanada
-
Hospital Ernesto DornellesUnknownPTSD | Depressive Symptoms | Anxiety Symptoms | Intensive Care Unit Syndrome | Post Intensive Care Unit SyndromeBrazil
-
Academisch Medisch Centrum - Universiteit van Amsterdam...ZonMw: The Netherlands Organisation for Health Research and Development; THE...Not yet recruitingSepsis | Critical Illness | Post Intensive Care Unit Syndrome | Intensive Care Unit Survivors | Microbiome Dysbiosis
Clinical Trials on VANDERBILT ICU RECOVERY PROGRAM
-
Holbaek SygehusHillerod Hospital, DenmarkCompleted
-
University of KentuckyAshley Montgomery-YatesCompletedCovid-19 | Critical Illness | Muscle Weakness | Post Intensive Care Unit SyndromeUnited States
-
Vanderbilt UniversityNational Institute on Aging (NIA); Ohio State UniversityRecruitingPost-intensive Care SyndromeUnited States
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompleted
-
Philipps University Marburg Medical CenterPflegeverbund Mitte-Süd; Stabstelle Pflegeforschung; Institut für Theoretische... and other collaboratorsCompletedHeart DiseasesGermany
-
Firat UniversityNot yet recruiting
-
National Cheng-Kung University HospitalCompleted
-
Cliniques universitaires Saint-Luc- Université...Completed
-
Hospices Civils de LyonInstitut National de la Santé Et de la Recherche Médicale, FranceCompleted
-
University Hospital, AngersCompletedSurgery | Small Bowel ObstructionFrance